Kathryn Loydall, PhD
Articles by Kathryn Loydall, PhD
Fragile mRNA molecules depend on protective carriers to transport them into cells.
| 1 min read
| 1 min read
The history of antibody research has led to modern immunotherapy treatments for infectious diseases.
| 1 min read
The recent COVID-19 mRNA vaccines represent a new wave of vaccines based on mRNA technology.
Methods for identifying single nucleotide polymorphisms reveal insights into disease pathogenesis, disease susceptibility, and drug response.
| 6 min read
From excising integrated viral sequences to modifying stem cells, CRISPR offers new possibilities for developing HIV treatments.
| 5 min read
Bacteria engineered to produce therapeutics fill a niche for patients with unmet medical needs.
Page 1 of 1 - 7 Total Items
